Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer
2019891 citationsKim N., Neeraj Agarwal et al.profile →
Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study
2021285 citationsKim N., Simon Chowdhury et al.profile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Byung Ha Chung
Since
Specialization
Citations
This map shows the geographic impact of Byung Ha Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Byung Ha Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Byung Ha Chung more than expected).
This network shows the impact of papers produced by Byung Ha Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Byung Ha Chung. The network helps show where Byung Ha Chung may publish in the future.
Co-authorship network of co-authors of Byung Ha Chung
This figure shows the co-authorship network connecting the top 25 collaborators of Byung Ha Chung.
A scholar is included among the top collaborators of Byung Ha Chung based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Byung Ha Chung. Byung Ha Chung is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Cho, Jin Seon, Chun Il Kim, Do Hwan Seong, et al.. (2005). Cut-off Point of Large Prostate Volume for the Patients with Benign Prostatic Hyperplasia. Korean Journal of Urology. 46(12). 1246–1250.9 indexed citations
10.
Chung, Byung Ha, Kwangmo Yang, & Sung Joon Hong. (2005). Meta-analysis of alpha receptor antagonist for benign prostatic hyperplasia from papers that were published in Korea. Korean journal of urology. 46(3). 252–258.1 indexed citations
11.
Chung, Byung Ha, Yong‐Soo Kim, & Sung Joon Hong. (2005). 12-month Follow-up Study to Evaluate the Efficacy and Safety of Doxazosin GITS in Patients with Benign Prostatic Hyperplasia. Korean journal of urology. 46(5). 451–457.3 indexed citations
12.
Cho, Jin Seon, Chun Il Kim, Do Hwan Seong, et al.. (2005). Relationship between serum prostate-specific antigen and prostate volume in men with benign prostatic hyperplasia from multicenter study. Korean Journal of Urology. 46(8). 792–798.4 indexed citations
13.
Han, Kyung Seok, Sung Joon Hong, & Byung Ha Chung. (2005). Changing Trends in the Management of Benign Prostatic Hyperplasia during Recent 5 Years. Korean journal of urology. 46(5). 458–462.7 indexed citations
14.
Lee, Jae Seok, et al.. (2005). A Validation and Reliability Study for the Korean Version of the Male Sexual Health Questionnaire. Korean journal of urology. 46(12). 1308–1326.5 indexed citations
15.
Yang, Won Jae, Young Deuk Choi, Byung Ha Chung, et al.. (2005). The significance of repeat prostate biopsy for the detection of prostate cancer. Korean journal of urology. 46(12). 1268–1271.2 indexed citations
16.
Im, Young Jae, Sung Joon Hong, & Byung Ha Chung. (2004). Clinical Application of Free to Total PSA Ratio in Detection of Prostate Cancer in Korean Men : Lower Cut-off Value. Korean journal of urology. 45(8). 753–757.1 indexed citations
17.
Lee, Jung-Il, et al.. (2002). A Case of Granulomatous Hepatitis Developed after Intravesical BCG Instillation for Bladder Cancer. Korean Journal of Gastroenterology. 39(5). 375–378.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.